Please assess the completion status of the following clinical trial:

Trial Title: Vitamin Therapy in Concussion Management: A Randomized Control Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects ages 11-22~* Concussion within 7 days of enrollment~* Presenting for treatment at Rothman Institute or Jefferson Concussion Center~Exclusion Criteria:~* Subjects with recent prior concussion within the past 30 days~* Subjects with a history of moderate to severe TBI requiring hospitalization or resulting in prolonged symptoms (\>3weeks).~* Subjects with known neurologic diagnosis associated with impaired cognitive function other that Attention Deficit Hyperactive Disorder or Attention Deficit Disorder.~* Subjects with know allergy to algae, omega-3 fatty acid, or any component of the formulation.~* Subjects currently requiring anticoagulants (ie- Warfarin), anti-platelets (ie- Aspirin, Plavix), or any non-steroidal anti-inflammatory drugs (ie- Ibuprofen, Naprosyn).~* Subjects with known liver pathology or significantly elevated liver function tests (greater than 3 X normal).~* Subjects with a current lower extremity injury that will affect postural stability testing.~* Subjects who are pregnant and/or breast feeding.

- Gender: ALL
- Minimum Age: 11 Years
- Maximum Age: 22 Years
- Healthy Volunteers: t

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): Non-nutritional non-immunogenic non-allergic oil-based capsule with same appearance, weight and density of active experimental vitamin.
- Experimental: Vitamin Mixture (Type: EXPERIMENTAL): Vitamin coenzyme Q10, magnesium, riboflavin and omega-3-fatty acid combination.

Based on this trial design, predict the completion outcome and termination type (if applicable).